What is Ocaliva in the UK?
Ocaliva is the brand name of obeticholic acid, a prescription medicine used in specific liver and bile-duct conditions. In the UK, Ocaliva is offered for patients with particular types of primary biliary cholangitis (PBC), based on the exact treatment eligibility set by UK guidance and prescribing rules [1].
Which conditions is Ocaliva used for?
Ocaliva is used to treat primary biliary cholangitis (PBC). Use in the UK depends on disease subtype and prior treatment history, because eligibility is tied to licensed indications and specialist assessment [1].
Who prescribes Ocaliva in the UK?
In practice, Ocaliva is typically prescribed by gastroenterology or hepatology specialists managing PBC, with follow-up monitoring of liver blood tests and response to therapy as recommended in clinical and prescribing guidance [1].
How do UK patients access Ocaliva?
Access is generally through NHS specialist care once clinicians decide the patient meets the licensed indication and treatment criteria. The NHS commissioning/authorization route can vary depending on local pathways and whether the patient qualifies under relevant criteria [1].
What monitoring and safety issues do UK patients usually ask about?
For Ocaliva, clinicians commonly monitor liver function tests and assess tolerability during treatment, since patients can experience side effects and abnormal liver tests. What monitoring is required can vary by patient condition and concurrent treatments, and it is directed by the prescribing specialist and the medicine’s UK documentation [1].
Is Ocaliva available on the NHS in the UK?
Availability on the NHS depends on the licensed indication and local funding/commissioning decisions, but the medicine is used in the UK health system for eligible patients under specialist care [1].
Sources
- https://www.ema.europa.eu/en/medicines/human/EPAR/ocaliva